Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer
- 1 January 1993
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 28 (3) , 277-284
- https://doi.org/10.1007/bf00666589
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Locally Advanced Breast Cancer: A Review Including the M.D. Anderson ExperiencePublished by Springer Nature ,1991
- Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Sixteen-Week Dose-Intense Chemotherapy in the Adjuvant Treatment of Breast CancerJNCI Journal of the National Cancer Institute, 1990
- Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study.Journal of Clinical Oncology, 1988
- NEOADJUVANT CHEMOTHERAPY IN THE COMBINED MODALITY APPROACH OF LOCALLY ADVANCED NONMETASTATIC BREAST-CANCER1987
- The importance of dose intensity in chemotherapy of metastatic breast cancer.Journal of Clinical Oncology, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958